AGC Biologics doubles mammalian capacity

Contract Development and Manufacturing Organisations (CDMOs) are playing an increasingly critical role in the large molecule drug market.

The biopharmaceutical CDMO market continues to grow in double digits annually. With scientific ability and ingenuity, the latest technology, and copious manufacturing capacity, these partners are now critical to the ecosystem. A notable example of this is AGC Biologics, one of the fastest-growing CDMOs in the life sciences space. In the last few years, the company has expanded at sites in Japan, USA, Germany, and Italy.

The CDMO is also finishing one of the biologics industry’s most extensive expansion…